2026 Global: In-Vitro Fertilization (Ivf) Syringes Market -Competitive Review (2032) report
Description
The 2026 Global: In-Vitro Fertilization (Ivf) Syringes Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Becton, Dickinson and Company (BD) dominates the IVF syringes segment with its extensive line of sterile syringes, transfer devices, and related consumables used in oocyte retrieval and embryo handling. Its global manufacturing footprint supports uninterrupted supply to fertility clinics across regions, reinforcing quality controls aligned with international standards. HQ: Franklin Lakes, New Jersey, USA. Terumo Corporation, based in Tokyo, Japan, offers an expansive portfolio of high-purity syringes and single-use devices that meet the sterility and precision requirements of assisted reproduction procedures. Nipro Corporation, headquartered in Osaka, Japan, supplies precision syringes and related devices designed to minimize contamination risks during drug administration and embryo handling. B. Braun Melsungen AG, headquartered in Melsungen, Germany, provides IV administration sets and syringes that support IVF workflows from hormone regimens to embryo transfer, emphasizing safety and reliability. Cardinal Health, headquartered in Dublin, Ohio, USA, distributes and brands sterile syringes to fertility clinics worldwide, ensuring robust supply chains, regulatory adherence, and cross-border compatibility of products.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, USA, supplies syringe sets and related IV accessories essential to controlled drug administration in IVF operations. Weigao Group Co., Ltd., based in Weihai, Shandong, China, manufactures high-volume sterile syringes and disposable devices deployed in IVF centers across Asia and beyond. Sarstedt AG & Co. KG, headquartered in Nümbrecht, Germany, is recognized for its comprehensive line of disposable syringes, needles, and lab consumables used in fertility procedures and embryo-handling workflows. Kawasumi Laboratories, Ltd., headquartered in Osaka, Japan, specializes in precision medical devices including syringes and catheters tailored to IVF workflows, embryo transfer, and hormonal regimens. Vygon SA, headquartered in Ecouen, France, supplies disposable syringes and IV administration components used in fertility clinics worldwide, with a focus on single-use sterile devices and integrated infusion sets.
Together, these ten manufacturers anchor a market characterized by strict sterility, traceability, and compatibility with diverse fertility protocols. The leading suppliers—BD, Terumo, Nipro, B. Braun, Cardinal Health, Teleflex, Weigao, Sarstedt, Kawasumi, and Vygon—operate extensive regional networks, invest in ISO 13485-compliant quality systems, and pursue product standardization that supports cross-border clinical practice. In IVF settings, syringes must deliver precise volumes, minimize residual carryover, and integrate seamlessly with hormone regimens, follicular aspiration, and embryo transfer workflows — a challenge these companies meet through process validation, sterile packaging, and robust supply chains. Regulatory landscapes differ by market, but the top players maintain global regulatory dossiers, CE labeling for Europe, FDA registration for the United States, and stringent quality controls to ensure patient safety. The result is a competitive yet convergent market in which innovation focuses on reducing contamination risk, improving ease of use, and enabling clinic-wide inventory management, while continuing to scale manufacturing to meet rising demand in North America, Europe, and Asia-Pacific globally.
Becton, Dickinson and Company (BD) dominates the IVF syringes segment with its extensive line of sterile syringes, transfer devices, and related consumables used in oocyte retrieval and embryo handling. Its global manufacturing footprint supports uninterrupted supply to fertility clinics across regions, reinforcing quality controls aligned with international standards. HQ: Franklin Lakes, New Jersey, USA. Terumo Corporation, based in Tokyo, Japan, offers an expansive portfolio of high-purity syringes and single-use devices that meet the sterility and precision requirements of assisted reproduction procedures. Nipro Corporation, headquartered in Osaka, Japan, supplies precision syringes and related devices designed to minimize contamination risks during drug administration and embryo handling. B. Braun Melsungen AG, headquartered in Melsungen, Germany, provides IV administration sets and syringes that support IVF workflows from hormone regimens to embryo transfer, emphasizing safety and reliability. Cardinal Health, headquartered in Dublin, Ohio, USA, distributes and brands sterile syringes to fertility clinics worldwide, ensuring robust supply chains, regulatory adherence, and cross-border compatibility of products.
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, USA, supplies syringe sets and related IV accessories essential to controlled drug administration in IVF operations. Weigao Group Co., Ltd., based in Weihai, Shandong, China, manufactures high-volume sterile syringes and disposable devices deployed in IVF centers across Asia and beyond. Sarstedt AG & Co. KG, headquartered in Nümbrecht, Germany, is recognized for its comprehensive line of disposable syringes, needles, and lab consumables used in fertility procedures and embryo-handling workflows. Kawasumi Laboratories, Ltd., headquartered in Osaka, Japan, specializes in precision medical devices including syringes and catheters tailored to IVF workflows, embryo transfer, and hormonal regimens. Vygon SA, headquartered in Ecouen, France, supplies disposable syringes and IV administration components used in fertility clinics worldwide, with a focus on single-use sterile devices and integrated infusion sets.
Together, these ten manufacturers anchor a market characterized by strict sterility, traceability, and compatibility with diverse fertility protocols. The leading suppliers—BD, Terumo, Nipro, B. Braun, Cardinal Health, Teleflex, Weigao, Sarstedt, Kawasumi, and Vygon—operate extensive regional networks, invest in ISO 13485-compliant quality systems, and pursue product standardization that supports cross-border clinical practice. In IVF settings, syringes must deliver precise volumes, minimize residual carryover, and integrate seamlessly with hormone regimens, follicular aspiration, and embryo transfer workflows — a challenge these companies meet through process validation, sterile packaging, and robust supply chains. Regulatory landscapes differ by market, but the top players maintain global regulatory dossiers, CE labeling for Europe, FDA registration for the United States, and stringent quality controls to ensure patient safety. The result is a competitive yet convergent market in which innovation focuses on reducing contamination risk, improving ease of use, and enabling clinic-wide inventory management, while continuing to scale manufacturing to meet rising demand in North America, Europe, and Asia-Pacific globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
